Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and Ofatumumab

NCT01125787 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low enrollment

Conditions

Chronic Lymphocytic Leukemia (CLL)

Interventions

DRUG: ofatumumab + bendamustine

Sponsor

Nevada Cancer Institute

Collaborators

[object Object]
[object Object]